Short-term effects of antipsychotic treatment on cerebral function in drug-naive first-episode schizophrenia revealed by "resting state" functional magnetic resonance imaging.

CONTEXT Most of what we know about antipsychotic drug effects is at the receptor level, distal from the neural system effects that mediate their clinical efficacy. Studying cerebral function in antipsychotic-naive patients with schizophrenia before and after pharmacotherapy can enhance understanding of the therapeutic mechanisms of these clinically effective treatments. OBJECTIVE To examine alterations of regional and neural network function in antipsychotic-naive patients with first-episode schizophrenia before and after treatment with second-generation antipsychotic medication. DESIGN Case-control study. SETTING Huaxi MR Research Center and Mental Health Centre of the West China Hospital. PARTICIPANTS Thirty-four antipsychotic-naive patients with first-episode schizophrenia were scanned using gradient-echo echo-planar imaging while in a resting state. After 6 weeks of antipsychotic treatment, patients were rescanned. Thirty-four matched healthy control subjects were studied at baseline for comparison purposes. MAIN OUTCOME MEASURES The amplitude of low-frequency fluctuations (ALFF) of blood oxygen level-dependent signals, believed to reflect spontaneous neural activity, was used to characterize regional cerebral function. Functional connectivity across brain regions was evaluated using a seed voxel correlation approach and an independent component analysis. Changes in these measures after treatment were examined to characterize effects of antipsychotic drugs on regional function and functional integration. RESULTS After short-term treatment with second-generation antipsychotic medications, patients showed increased ALFF, particularly in the bilateral prefrontal and parietal cortex, left superior temporal cortex, and right caudate nucleus. Increased regional ALFF was associated with a reduction of clinical symptoms, and a widespread attenuation in functional connectivity was observed that was correlated with increased regional ALFF. CONCLUSIONS We demonstrate for the first time, to our knowledge, that widespread increased regional synchronous neural activity occurs after antipsychotic therapy, accompanied by decreased integration of function across widely distributed neural networks. These findings contribute to the understanding of the complex systems-level effects of antipsychotic drugs.

[1]  B. Biswal,et al.  The resting brain: unconstrained yet reliable. , 2009, Cerebral cortex.

[2]  Qiyong Gong,et al.  High-field MRI reveals an acute impact on brain function in survivors of the magnitude 8.0 earthquake in China , 2009, Proceedings of the National Academy of Sciences.

[3]  M. Minzenberg,et al.  Meta-analysis of 41 functional neuroimaging studies of executive function in schizophrenia. , 2009, Archives of general psychiatry.

[4]  D. Collier,et al.  Association of cerebral deficits with clinical symptoms in antipsychotic-naive first-episode schizophrenia: an optimized voxel-based morphometry and resting state functional connectivity study. , 2009, The American journal of psychiatry.

[5]  J. Tregellas.  Connecting brain structure and function in schizophrenia. , 2009, The American journal of psychiatry.

[6]  K. Hugdahl,et al.  Left Temporal Lobe Structural and Functional Abnormality Underlying Auditory Hallucinations in Schizophrenia , 2008, Front. Neurosci..

[7]  J. Sweeney,et al.  Effects of Risperidone on Procedural Learning in Antipsychotic-Naive First-Episode Schizophrenia , 2009, Neuropsychopharmacology.

[8]  Sarah E. Forster,et al.  Subunit-selective modulation of GABA type A receptor neurotransmission and cognition in schizophrenia. , 2008, The American journal of psychiatry.

[9]  J. Sweeney,et al.  Effects of second-generation antipsychotic medication on smooth pursuit performance in antipsychotic-naive schizophrenia. , 2008, Archives of general psychiatry.

[10]  Donard S Dwyer,et al.  Antipsychotic Drugs: Comparison in Animal Models of Efficacy, Neurotransmitter Regulation, and Neuroprotection , 2008, Pharmacological Reviews.

[11]  B. Harrison,et al.  Consistency and functional specialization in the default mode brain network , 2008, Proceedings of the National Academy of Sciences.

[12]  D. Leopold,et al.  Neuronal correlates of spontaneous fluctuations in fMRI signals in monkey visual cortex: Implications for functional connectivity at rest , 2008, Human brain mapping.

[13]  V. Calhoun,et al.  Modulation of temporally coherent brain networks estimated using ICA at rest and during cognitive tasks , 2008, Human brain mapping.

[14]  Mark Slifstein,et al.  Dose–Occupancy Study of Striatal and Extrastriatal Dopamine D2 Receptors by Aripiprazole in Schizophrenia with PET and [18F]Fallypride , 2008, Neuropsychopharmacology.

[15]  Vince D. Calhoun,et al.  A method for functional network connectivity among spatially independent resting-state components in schizophrenia , 2008, NeuroImage.

[16]  J. Sweeney,et al.  Antipsychotic Drugs Exacerbate Impairment on a Working Memory Task in First-Episode Schizophrenia , 2007, Biological Psychiatry.

[17]  M. Fox,et al.  Spontaneous fluctuations in brain activity observed with functional magnetic resonance imaging , 2007, Nature Reviews Neuroscience.

[18]  Raquel E Gur,et al.  Deconstructing psychosis with human brain imaging. , 2007, Schizophrenia bulletin.

[19]  R. Bluhm,et al.  Spontaneous low-frequency fluctuations in the BOLD signal in schizophrenic patients: anomalies in the default network. , 2007, Schizophrenia bulletin.

[20]  Olaf Sporns,et al.  Network structure of cerebral cortex shapes functional connectivity on multiple time scales , 2007, Proceedings of the National Academy of Sciences.

[21]  Chaozhe Zhu,et al.  Amplitude of low frequency fluctuation within visual areas revealed by resting-state functional MRI , 2007, NeuroImage.

[22]  Yuan Zhou,et al.  Functional dysconnectivity of the dorsolateral prefrontal cortex in first-episode schizophrenia using resting-state fMRI , 2007, Neuroscience Letters.

[23]  V. Calhoun,et al.  Functional neural circuits for mental timekeeping , 2007, Human brain mapping.

[24]  V. Calhoun,et al.  Aberrant "default mode" functional connectivity in schizophrenia. , 2007, The American journal of psychiatry.

[25]  Scott T. Grafton,et al.  Wandering Minds: The Default Network and Stimulus-Independent Thought , 2007, Science.

[26]  David A Lewis,et al.  Cognitive dysfunction in schizophrenia: convergence of gamma-aminobutyric acid and glutamate alterations. , 2006, Archives of neurology.

[27]  Peter A. Bandettini,et al.  Separating respiratory-variation-related fluctuations from neuronal-activity-related fluctuations in fMRI , 2006, NeuroImage.

[28]  Natasha M. Maurits,et al.  Correlating the alpha rhythm to BOLD using simultaneous EEG/fMRI: Inter-subject variability , 2006, NeuroImage.

[29]  Steven B. Lowen,et al.  Emotional task-dependent low-frequency fluctuations and methylphenidate: Wavelet scaling analysis of 1/f-type fluctuations in fMRI of the cerebellar vermis , 2006, Journal of Neuroscience Methods.

[30]  Stephen M. Smith,et al.  fMRI resting state networks define distinct modes of long-distance interactions in the human brain , 2006, NeuroImage.

[31]  Yuan Zhou,et al.  Widespread functional disconnectivity in schizophrenia with resting-state functional magnetic resonance imaging , 2006, Neuroreport.

[32]  T. Crow,et al.  Regional deficits in brain volume in schizophrenia: a meta-analysis of voxel-based morphometry studies. , 2005, The American journal of psychiatry.

[33]  M. Lowe,et al.  Activity and Connectivity of Brain Mood Regulating Circuit in Depression: A Functional Magnetic Resonance Study , 2005, Biological Psychiatry.

[34]  M. Desco,et al.  Olanzapine-induced cerebral metabolic changes related to symptom improvement in schizophrenia , 2005, International clinical psychopharmacology.

[35]  B. Gillain,et al.  P.2.062 The short-term effect of orally disintegrating olanzapine tablets on agitation and cooperation in clinical practice , 2004, European Neuropsychopharmacology.

[36]  S. Tuinier,et al.  Atypical antipsychotics and the relevance of glutamate and serotonin , 2004, European Neuropsychopharmacology.

[37]  V. Calhoun,et al.  Aberrant localization of synchronous hemodynamic activity in auditory cortex reliably characterizes schizophrenia , 2004, Biological Psychiatry.

[38]  E. Klein,et al.  Mitochondrial complex i subunits expression is altered in schizophrenia: a postmortem study , 2004, Biological Psychiatry.

[39]  M. Greicius,et al.  Default-mode network activity distinguishes Alzheimer's disease from healthy aging: Evidence from functional MRI , 2004, Proc. Natl. Acad. Sci. USA.

[40]  Nikos K Logothetis,et al.  Interpreting the BOLD signal. , 2004, Annual review of physiology.

[41]  K. Hugdahl,et al.  Brain activation measured with fMRI during a mental arithmetic task in schizophrenia and major depression. , 2004, The American journal of psychiatry.

[42]  M. Egan,et al.  Complexity of prefrontal cortical dysfunction in schizophrenia: more than up or down. , 2003, The American journal of psychiatry.

[43]  A. Kleinschmidt,et al.  Electroencephalographic signatures of attentional and cognitive default modes in spontaneous brain activity fluctuations at rest , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[44]  Carol A Tamminga,et al.  Functional effects of antipsychotic drugs: comparing clozapine with haloperidol , 2003, Biological Psychiatry.

[45]  M. Desco,et al.  Cerebral metabolism and risperidone treatment in schizophrenia , 2003, Schizophrenia Research.

[46]  N. Andreasen,et al.  The effects of neuroleptic medications on basal ganglia blood flow in schizophreniform disorders: a comparison between the neuroleptic-naïve and medicated states , 2002, Biological Psychiatry.

[47]  Ewald Moser,et al.  On the origin of respiratory artifacts in BOLD-EPI of the human brain. , 2002, Magnetic resonance imaging.

[48]  H. Tost,et al.  Sensory information processing in neuroleptic-naive first-episode schizophrenic patients: a functional magnetic resonance imaging study. , 2002, Archives of general psychiatry.

[49]  P. Liddle,et al.  Immediate and delayed effects of risperidone on cerebral metabolism in neuroleptic naïve schizophrenic patients: correlations with symptom change , 2002, Journal of neurology, neurosurgery, and psychiatry.

[50]  J. Blass.  Glucose/mitochondria in neurological conditions. , 2002, International review of neurobiology.

[51]  V. Haughton,et al.  Frequencies contributing to functional connectivity in the cerebral cortex in "resting-state" data. , 2001, AJNR. American journal of neuroradiology.

[52]  G L Shulman,et al.  INAUGURAL ARTICLE by a Recently Elected Academy Member:A default mode of brain function , 2001 .

[53]  T Adali,et al.  A weighted least‐squares algorithm for estimation and visualization of relative latencies in event‐related functional MRI , 2000, Magnetic resonance in medicine.

[54]  B. Biswal,et al.  Cocaine administration decreases functional connectivity in human primary visual and motor cortex as detected by functional MRI , 2000, Magnetic resonance in medicine.

[55]  P. Liddle.  Cognitive impairment in schizophrenia:its impact on social functioning , 2000, Acta psychiatrica Scandinavica. Supplementum.

[56]  T. Wassink,et al.  Defining the phenotype of schizophrenia: cognitive dysmetria and its neural mechanisms , 1999, Biological Psychiatry.

[57]  J. Haxby,et al.  Localization of Cardiac-Induced Signal Change in fMRI , 1999, NeuroImage.

[58]  J. Lieberman,et al.  The effects of atypical antipsychotic drugs on neurocognitive impairment in schizophrenia: a review and meta-analysis. , 1999, Schizophrenia bulletin.

[59]  J. Korf,et al.  Prefrontal involvement in schizophrenia , 1998, Schizophrenia Research.

[60]  M. Losonczy,et al.  Regional cerebral blood flow changes associated with risperidone treatment in elderly schizophrenia patients: a pilot study. , 1996, Psychopharmacology bulletin.

[61]  D R Medoff,et al.  Functional sites of neuroleptic drug action in the human brain: PET/FDG studies with and without haloperidol. , 1996, The American journal of psychiatry.

[62]  Terrence J. Sejnowski,et al.  An Information-Maximization Approach to Blind Separation and Blind Deconvolution , 1995, Neural Computation.

[63]  N C Andreasen,et al.  Hypofrontality in neuroleptic-naive patients and in patients with chronic schizophrenia. Assessment with xenon 133 single-photon emission computed tomography and the Tower of London. , 1992, Archives of general psychiatry.

[64]  M S Buchsbaum,et al.  Glucose Metabolic Rate in Normals and Schizophrenics During the Continuous Performance Test Assessed by Positron Emission Tomography , 1990, British Journal of Psychiatry.

[65]  A. Alavi,et al.  Regional brain function in schizophrenia. I. A positron emission tomography study. , 1987, Archives of general psychiatry.

[66]  S. Kay,et al.  The positive and negative syndrome scale (PANSS) for schizophrenia. , 1987, Schizophrenia bulletin.